Basic Information
Basic information for TMEM161B-AS1-245-22aa
Peptide Name TMEM161B-AS1-245-22aa
Genome Position chr5:88292936-88293001[+]
Species Human
Peptide Sequence MELNLGKAHFYLYIKQLQPCTS
Peptide Length 22
Unique No (TMEM161B-AS1-215-22aa,TMEM161B-AS1-216-22aa-1,TMEM161B-AS1-225-22aa-1,TMEM161B-AS1-227-22aa,TMEM161B-AS1-230-22aa-1,TMEM161B-AS1-238-22aa,TMEM161B-AS1-241-22aa-1,TMEM161B-AS1-248-22aa,TMEM161B-AS1-254-22aa,TMEM161B-AS1-257-22aa-2,TMEM161B-AS1-258-22aa-1)
Grand Average of Hydropathicity -0.1091
Relative Molecular Mass 2976.42
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000247828;TMEM161B-AS1
Transcript ID/Name ENST00000666577;TMEM161B-AS1-245
Transcript Length 2493
Coding Ability 0.3939
DNA Sequence Corresponding to Peptide ATGGAATTAAATTTAGGCAAAGCTCACTTTTATTTATACATAAAACAACTTCAGCCATGTACCTCA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :